Amanda Cashen

Trials

Studies that name Amanda Cashen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:55 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04893915 · Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS

  Washington University School of Medicine · withdrawn · Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes · principal investigator
• Ph2
  NCT04331119 · Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas

  Washington University School of Medicine · terminated · T-Cell Lymphoma · principal investigator
• Ph1/Ph2
  NCT03068819 · Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

  Washington University School of Medicine · completed · Acute Myeloid Leukemia · principal investigator
• Ph2
  NCT02782546 · Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

  Washington University School of Medicine · active not recruiting · Acute Myeloid Leukemia · principal investigator
• Early Ph1
  NCT02117115 · Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

  Washington University School of Medicine · completed · Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelogenous, Chronic · principal investigator
• Ph2
  NCT01969435 · Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma

  Washington University School of Medicine · completed · Hodgkin Disease, Lymphoma, Non-Hodgkin · principal investigator
• Ph1/Ph2
  NCT01898793 · Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

  Washington University School of Medicine · terminated · Leukemia, Myeloid, Acute · principal investigator
• Ph1
  NCT01001143 · Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)

  Washington University School of Medicine · completed · Leukemia, Myeloid, Acute · principal investigator
• Ph2
  NCT00865969 · Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

  Spectrum Pharmaceuticals, Inc · completed · Peripheral T-cell Lymphoma · principal investigator
• N/A
  NCT00590941 · Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma

  Washington University School of Medicine · completed · Lymphoma, Diffuse Large Cell · principal investigator
• Ph2
  NCT00357162 · Belinostat in Treating Patients With Myelodysplastic Syndromes

  National Cancer Institute (NCI) · completed · de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Secondary Myelodysplastic Syndromes · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Clinical Protocol and Data Management
  P30CA091842 · NCI · WASHINGTON UNIVERSITY · fiscal years 2026 · $832,810 awarded in 2026
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Core A: Biospecimen Processing
  P50CA171963 · NCI · WASHINGTON UNIVERSITY · PI MEAGAN JACOBY · fiscal years 2016 to 2026
  Named on NCT03068819, NCT02782546
• Mechanisms underlying cytokine-induced memory-like natural killer cell differentiation and maintenance.
  F32CA200253 · NCI · WASHINGTON UNIVERSITY · PI Melissa Berrien Elliott · fiscal years 2016 to 2017
  Named on NCT01898793
• Pathology Research Shared Resource
  P30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI THOMAS J FLOTTE · fiscal years 2016 to 2026
  Named on NCT00357162